BioNukleo set up enzyme libraries for nucleoside phoshorylases and nucleoside/nucleotide kinases. The enzymes are well characterized and possess a large substrate promiscuity. Detailed protocols were developed which enable customers to produce nucleoside and nucleotide analogues which high yields and excellent purity.
BioNukleo offers the development of custom-specific synthesis routes for the enzymatic production of modified nucleosides and nucleotides. Furthermore, BioNukleo offers customized contract research.
BioNukleo presented its enzymatic technology for the production of modified nucleosides and nucleotides on the Peptalk which took places January 8-12, 2018 in San Diego